About Christopher Powala
Form D filings for NFlection Therapeutics from 2020 to 2023 list Christopher Powala as director.
Christopher Powala first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Powala in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Powala works with at each company, as listed on that company's latest Form D.
NFlection Therapeutics, Inc. · Form D, Jul 21, 2023
KP
Ketan Patel
Director
WH
William Hodder
President and Director
CG
Corey Goodman
Director
JG
Josh Grass
Director